Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: Predictors of Gamma Glutamyltransferase Normalization and Favorable Clinical Course.

Authors

Mark Deneau
Emily Perito
Amanda Ricciuto
Nitika Gupta
Binita M Kamath
Sirish Palle
Bernadette Vitola
Vratislav Smolka
Federica Ferrari
Achiya Z Amir
Tamir Miloh
Alexandra Papadopoulou
Parvathi Mohan, George Washington University
Cara Mack
Kaija-Leena Kolho
Raffaele Iorio
Wael El-Matary
Veena Venkat
Albert Chan
Lawrence Saubermann
Pamela L Valentino
Uzma Shah
Alexander Miethke
Henry Lin
M K Jensen

Document Type

Journal Article

Publication Date

3-13-2019

Journal

The Journal of pediatrics

DOI

10.1016/j.jpeds.2019.01.039

Comments

Epub ahead of print

APA Citation

Deneau, M., Perito, E., Ricciuto, A., Gupta, N., Kamath, B., Palle, S., Vitola, B., Smolka, V., Ferrari, F., Amir, A., Miloh, T., Papadopoulou, A., Mohan, P., Mack, C., Kolho, K., Iorio, R., El-Matary, W., Venkat, V., Chan, A., Saubermann, L., Valentino, P., Shah, U., Miethke, A., Lin, H., & Jensen, M. (2019). Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: Predictors of Gamma Glutamyltransferase Normalization and Favorable Clinical Course.. The Journal of pediatrics, (). http://dx.doi.org/10.1016/j.jpeds.2019.01.039

Peer Reviewed

1